Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $12,291 - $13,997
-58 Reduced 33.33%
116 $28,000
Q1 2023

May 12, 2023

BUY
$213.32 - $257.83 $17,918 - $21,657
84 Added 93.33%
174 $40,000
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $14,871 - $18,174
73 Added 429.41%
90 $21,000
Q3 2022

Nov 02, 2022

SELL
$204.81 - $262.19 $36,251 - $46,407
-177 Reduced 91.24%
17 $3,000
Q2 2022

Aug 02, 2022

BUY
$213.86 - $277.87 $33,362 - $43,347
156 Added 410.53%
194 $45,000
Q1 2022

May 11, 2022

BUY
$259.82 - $298.18 $9,873 - $11,330
38 New
38 $10,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.